These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26396095)

  • 61. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
    Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.
    Gafni RI; Guthrie LC; Kelly MH; Brillante BA; Christie CM; Reynolds JC; Yovetich NA; James R; Collins MT
    J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
    Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
    Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Bone alkaline phosphatase and N-MID osteocalcin in monitoring of osteoporosis treatment with recombinant human parathyroid hormone 1-34].
    Weng XM; Pan JP
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):578-82. PubMed ID: 24167142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy.
    Kung AW; Chan TM; Lau CS; Wong RW; Yeung SS
    Rheumatology (Oxford); 1999 Dec; 38(12):1239-44. PubMed ID: 10587552
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preventing bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate.
    Magno C; Anastasi G; Morabito N; Gaudio A; Maisano D; Franchina F; Galì A; Frisina N; Melloni D
    Eur Urol; 2005 May; 47(5):575-80; discussion 580-1. PubMed ID: 15826746
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women.
    Malavolta N; Pratelli L; Frigato M; Mulè R; Mascia ML; Gnudi S
    Osteoporos Int; 2005 Dec; 16(12):1691-7. PubMed ID: 15959621
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Short-Term Effects of Kefir-Fermented Milk Consumption on Bone Mineral Density and Bone Metabolism in a Randomized Clinical Trial of Osteoporotic Patients.
    Tu MY; Chen HL; Tung YT; Kao CC; Hu FC; Chen CM
    PLoS One; 2015; 10(12):e0144231. PubMed ID: 26655888
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
    Laway BA; Goswami R; Singh N; Gupta N; Seith A
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.
    Scholz-Ahrens KE; Delling G; Stampa B; Helfenstein A; Hahne HJ; Açil Y; Timm W; Barkmann R; Hassenpflug J; Schrezenmeir J; Glüer CC
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E385-95. PubMed ID: 17456640
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
    Shane E; Addesso V; Namerow PB; McMahon DJ; Lo SH; Staron RB; Zucker M; Pardi S; Maybaum S; Mancini D
    N Engl J Med; 2004 Feb; 350(8):767-76. PubMed ID: 14973216
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women.
    Park JH; Park KH; Cho S; Choi YS; Seo SK; Lee BS; Park HS
    Menopause; 2013 Jul; 20(7):747-53. PubMed ID: 23511701
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of Glucocorticoid-Induced Osteoporosis with Bisphosphonates Alone, Vitamin D Alone or a Combination Treatment in Eastern Asians: A Meta-Analysis.
    Wang J; Li H
    Curr Pharm Des; 2019; 25(14):1653-1662. PubMed ID: 31218954
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevention of corticosteroid-induced osteoporosis by alfacalcidol.
    Lakatos P; Nagy Z; Kiss L; Horvath C; Takacs I; Foldes J; Speer G; Bossanyi A
    Z Rheumatol; 2000; 59 Suppl 1():48-52. PubMed ID: 10769437
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glucocorticoid effects on bone strength in children with renal diseases.
    Aoyagi J; Kanai T; Ito T; Odaka J; Saito T; Betsui H; Kurosaki M; Maru T; Yamagata T
    Nephrology (Carlton); 2021 Feb; 26(2):119-125. PubMed ID: 33207023
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Meta-Analysis of Effects of Nutritional Intervention Combined with Calcium Carbonate D3 Tablets on Bone Mineral Density, Bone Metabolism, and Curative Effect in Patients with Osteoporosis.
    Ni H; Zhang S; Niu X; Dai S
    Contrast Media Mol Imaging; 2022; 2022():3670007. PubMed ID: 35845743
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man.
    Gallacher SJ; Cowan RA; Fraser WD; Logue FC; Jenkins A; Boyle IT
    Eur J Endocrinol; 1994 Feb; 130(2):141-5. PubMed ID: 8130888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.